Want to join the conversation?
Similar to the past two quarters, $CERN delivered operating margins basically in line earnings on lower revenue in 3Q15. Operating margin before share-based compensation expenses, voluntary separation expense & acquisition-related adjustments is 24.5% in Q3, down 90BPs YoverY due mostly to the very low tech resale in 3Q14 & up 30BPs from 2Q15.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.